EPLR 3/2020 is out now
The third issue of the European Pharmaceutical Law Review in the 2020 is now available. The issue features articles on:
- Duplicate Marketing Authorisations in the EU
- Navigating Cross-Border Transfers in the Pharmaceutical Sector After Schrems II
- Stem Cell Based Products in Europe and in China
- The Impact of the Medical Devices Regulation on the Pharmaceutical Industry
As well as updates on the most recent court decisions and the latest policy developments.
View the whole table of content of EPLR 3/2020: Here
Become an Author for EPLR and view our Call for Papers